Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
When creating 3d plans using dose weighting mode if the user rescales the plan selects "reset" and then changes the wedge angle the plan dose and monitor units (mu) should be returned to the original values before the rescale. instead the system correctly restores the edited wedge field but incorrectly applies the scale reset value again to all other beams in the plan.